Cargando…

High Expression of Hyaluronan-Mediated Motility Receptor Predicts Adverse Outcomes: A Potential Therapeutic Target for Head and Neck Squamous Cell Carcinoma

Background: Several studies have shown that the hyaluronan-mediated motility receptor (HMMR) is overexpressed in various cancers and could be a potential prognostic factor. However, further research is still required to determine the prognostic value and potential function of HMMR in head and neck s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Tianzhu, Zheng, Yahan, Gong, Xiaochang, Lv, Qiaoli, Chen, Junjun, Tu, Ziwei, Lin, Shaojun, Pan, Jianji, Guo, Qiaojuan, Li, Jingao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982417/ https://www.ncbi.nlm.nih.gov/pubmed/33763352 http://dx.doi.org/10.3389/fonc.2021.608842

Ejemplares similares

SEC61G overexpression and DNA amplification correlates with prognosis and immune cell infiltration in head and neck squamous cell carcinoma
por: Lu, Tianzhu, et al.
Publicado: (2021)

A Signature of N(6)-methyladenosine Regulator-Related Genes Predicts Prognoses and Immune Responses for Head and Neck Squamous Cell Carcinoma
por: Chen, Junjun, et al.
Publicado: (2022)

Identification of immune‐related genes contributing to head and neck squamous cell carcinoma development using weighted gene co‐expression network analysis
por: Guo, Qiaojuan, et al.
Publicado: (2023)

Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma
por: Lin, Cheng, et al.
Publicado: (2023)

Comparison of an in‐house hybrid DIR method to NiftyReg on CBCT and CT images for head and neck cancer
por: Jiang, Chunling, et al.
Publicado: (2022)

Pretreatment Serum Lactate Dehydrogenase Level as an Independent Prognostic Factor of Nasopharyngeal Carcinoma in the Intensity-Modulated Radiation Therapy Era
por: Chen, Zhuhong, et al.
Publicado: (2017)

Prognostic Evaluation of Nasopharyngeal Carcinoma with Bone-Only Metastasis after Therapy
por: Lu, Tianzhu, et al.
Publicado: (2016)

Hyaluronan stimulates pancreatic cancer cell motility
por: Cheng, Xiao-Bo, et al.
Publicado: (2015)

Benefit of percutaneous endoscopic gastrostomy in patients undergoing definitive chemoradiotherapy for locally advanced nasopharyngeal carcinoma
por: Xu, Yun, et al.
Publicado: (2016)

Genetic variations in the PI3K-PTEN-AKT-mTOR pathway are associated with distant metastasis in nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy
por: Guo, Qiaojuan, et al.
Publicado: (2016)

Plasma Epstein-Barr Virus MicroRNA BART8-3p as a Diagnostic and Prognostic Biomarker in Nasopharyngeal Carcinoma
por: Lin, Cheng, et al.
Publicado: (2022)

High Soluble Programmed Death-Ligand 1 Predicts Poor Prognosis in Patients with Nasopharyngeal Carcinoma
por: Lu, Tianzhu, et al.
Publicado: (2020)

Selective Activation of Cancer Stem Cells by Size-Specific Hyaluronan in Head and Neck Cancer
por: Shiina, Marisa, et al.
Publicado: (2015)

Effects of oral maintenance chemotherapy and predictive value of circulating EBV DNA in metastatic nasopharyngeal carcinoma
por: Zhou, Han, et al.
Publicado: (2020)

Exosomes in Head and Neck Squamous Cell Carcinoma
por: Xiao, Cheng, et al.
Publicado: (2019)

Matrisomal genes in squamous cell carcinoma of head and neck influence tumor cell motility and response to cetuximab treatment
por: Goh, Kah Yee, et al.
Publicado: (2022)

Oral Maintenance Chemotherapy Using S-1/Capecitabine in Metastatic Nasopharyngeal Carcinoma Patients After Systemic Chemotherapy: A Single-Institution Experience
por: Guo, Qiaojuan, et al.
Publicado: (2020)

Stereotactic body radiotherapy extends the clinical benefit of PD-1 inhibitors in refractory recurrent/metastatic nasopharyngeal carcinoma
por: Lin, Jing, et al.
Publicado: (2022)

Systematic Analysis of the Clinical Significance of Hyaluronan-Mediated Motility Receptor in Colorectal Cancer
por: Tang, Yan-ping, et al.
Publicado: (2021)

Hyaluronan Mediated Motility Receptor (HMMR) Encodes an Evolutionarily Conserved Homeostasis, Mitosis, and Meiosis Regulator Rather than a Hyaluronan Receptor
por: He, Zhengcheng, et al.
Publicado: (2020)

Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
por: Cavalieri, Stefano, et al.
Publicado: (2021)

Targeted therapy for head and neck squamous cell carcinoma microenvironment
por: Guo, Zhaomeng, et al.
Publicado: (2023)

The characteristics and clinical relevance of tumor fusion burden in head and neck squamous cell carcinoma
por: He, Lirui, et al.
Publicado: (2022)

Is a high-risk clinical target volume required? Evaluation of the dosimetric feasibility based on T staging
por: Yuan, Xingxing, et al.
Publicado: (2022)

Correction. Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility
Publicado: (1992)

The hyaluronan-mediated motility receptor RHAMM promotes growth, invasiveness and dissemination of colorectal cancer
por: Mele, Valentina, et al.
Publicado: (2017)

Stanniocalcin 2 (STC2) expression promotes post-radiation survival, migration and invasion of nasopharyngeal carcinoma cells
por: He, Huocong, et al.
Publicado: (2019)

Circulating Epstein‐Barr virus microRNAs BART7‐3p and BART13‐3p as novel biomarkers in nasopharyngeal carcinoma
por: Lu, Tianzhu, et al.
Publicado: (2020)

Preventable burden of head and neck cancer attributable to tobacco and alcohol between 1990 and 2039 in China
por: Song, Cheng, et al.
Publicado: (2023)

Cutaneous Squamous Cell Carcinoma of the Head and Neck
por: Gurudutt, Vivek V., et al.
Publicado: (2011)

Hypoxia in Head and Neck Squamous Cell Carcinoma
por: Li, John Zenghong, et al.
Publicado: (2012)

Immunotherapy for head and neck squamous cell carcinoma
por: Fuereder, Thorsten
Publicado: (2016)

Immunotherapy for Head and Neck Squamous Cell Carcinoma
por: Moskovitz, Jessica, et al.
Publicado: (2018)

Immunotherapy in Head and Neck Squamous Cell Cancer
por: Denaro, Nerina, et al.
Publicado: (2018)

The Role of Inflammation-Associated Factors in Head and Neck Squamous Cell Carcinoma
por: Li, Kang, et al.
Publicado: (2023)

Survival analyses correlate stanniocalcin 2 overexpression to poor prognosis of nasopharyngeal carcinomas
por: Lin, Shaojun, et al.
Publicado: (2014)

Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells
por: Bourguignon, Lilly Y. W., et al.
Publicado: (2017)

Ron tyrosine kinase receptor synergises with EGFR to confer adverse features in head and neck squamous cell carcinoma
por: Keller, J, et al.
Publicado: (2013)

The tumor ecosystem in head and neck squamous cell carcinoma and advances in ecotherapy
por: Gong, Yingying, et al.
Publicado: (2023)

Hyaluronan Injections Show No Histologic Evidence of Adverse Tissue Effects
por: Bisogno, Michael, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ged3bjm9oia11cufsj3rr8l0so